PACS Group, Inc. (PACS) is a publicly traded Financial Services sector company. As of May 21, 2026, PACS trades at $37.00 with a market cap of $5.83B and a P/E ratio of 29.72. PACS moved +0.53% today. Year to date, PACS is -6.97%; over the trailing twelve months it is +251.04%. Its 52-week range spans $7.50 to $43.92. Analyst consensus is strong buy with an average price target of $48.80. Rallies surfaces PACS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
PACS Group Inc to Report Q1 2026 Results as Investors Weigh Value Versus Medpace: PACS Group Inc. is set to release its Q1 2026 results on May 11, detailing performance metrics for the medical services provider. Investors are evaluating PACS against Medpace by comparing valuation multiples and growth forecasts to determine the superior value opportunity.
| Metric | Value |
|---|---|
| Price | $37.00 |
| Market Cap | $5.83B |
| P/E Ratio | 29.72 |
| EPS | $1.23 |
| Dividend Yield | 0.00% |
| 52-Week High | $43.92 |
| 52-Week Low | $7.50 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $5.29B |
| Net Income | $191.46M |
| Gross Margin | 0.00% |
5 analysts cover PACS: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $48.80.